News

Team will present posters including 2 on ioCRISPR-Ready Cells & host an expert panel discussion on the important role of functiona...

Discover how a collaboration delivered bit.bio's ioGlutamatergic Neurons onto the stage at the Royal Institution to appear in the ...

Product will provide robust, standardised tool for study and screening of potential treatments for motor neuron diseases.

Minister Griffith cut the ribbon to officially open bit.bio’s manufacturing and automation labs for the consistent and scalable pr...

King's College London & bit.bio collaborate to develop multi-cell models of the human brain with optimised open-source protocols f...

Mark Kotter wins in two categories, Equity-Backed Entrepreneur of the Year and Purpose Entrepreneur of the Year, at the Great Brit...

Endpoints News did an exclusive interview with bit.bio's CEO after the cell therapy pipeline announcement with an initial focus on...

This episode of the Invent podcast features our director of cellular phenotyping Davide Danovi discussing innovations in cell ther...